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Tumor cell viabilityKindlin-2 is engaged in tumor progression. However, the mechanism accounting for Kindlin-2
regulation in tumor cells remained largely unknown. Here, we report a regulatory loop between
Kindlin-2 and GLI1, an effector of Hedgehog signaling pathway. We show that Kindlin-2 is transcrip-
tionally downregulated via GLI1 occupancy on the Kindlin-2 promoter. Adversely, we found that
Kindlin-2 promotes GLI1 expression through a mechanism involving GSK3b inactivation and is inde-
pendent of Smoothened. Functionally, knockdown of Kindlin-2 cooperates with cyclopamine, a
Smoothened antagonist, to decrease the viability of prostate cancer cells. Taken together, targeting
the Kindlin-2–GLI1 feedback loop may facilitate the killing of prostate cancer cells.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Kindlin-2 belongs to a novel family of focal adhesion proteins
consisting of three members, Kindlin-1, Kindlin-2 and Kindlin-3
(also known as FERMT1, FERMT2 and FERMT3). Kindlin-2 was ini-
tially identiﬁed as an integrin-interacting focal adhesion molecule
and was found to be essential for the regulation of integrin signal-
ing through direct interaction with the cytoplasmic tail of integrin
b3. Kindlin-2 cooperated with Talin to activate integrin aIIbb3
[1–5]. Loss of Kindlin-2 caused early embryonic lethality in mice
[3], whereas knockdown of Kindlin-2 homolog in Zebraﬁsh resulted
in severe abnormalities of heart development [6]. Furthermore,
loss of UNC-112, the homolog of Kindin-2 in Caenorhabditis elegans
leads to an embryonic lethal Pat (paralyzed, arrested elongation attwofold) phenotype [7,8]. These ﬁndings indicate that Kindlin-2 is
a biologically important molecule.
Recently, we and others found that Kindlin-2 was expressed dif-
ferentially in a variety of cancers including malignant mesotheli-
oma (MM) [9], breast cancer [10], uterine leiomyosarcoma [11]
and gastric cancer [12]. We found that Kindlin-2 was highly ex-
pressed in MM, and knockdown of Kindlin-2 with small interfering
RNA (siRNA) impaired MM cell spreading, adhesion and migration
[9]. Gozgit et al. [10] also obtained similar results in breast cancer
cells. Kindlin-2 was found highly expressed in androgen-
insensitive prostate cancer cells PC-3 and DU-145, and knockdown
of Kindlin-2 enhanced the sensitivity of PC-3 cells to cisplatin [13].
In addition, Kato et al. [11] reported that the expression of Kindlin-
2 was increased in leiomyomas but not in leiomyosarcomas.
Furthermore, knockdown of Kindlin-2 considerably increased the
invasiveness of mesenchymal cancer cells by inhibiting the secre-
tion of urokinase-type plasminogen activator (uPA) [14]. Our re-
cent ﬁndings demonstrated that Kindlin-2 is a Wnt signaling
regulator by forming a molecular complex with b-catenin and
TCF4 [15]. Taken together, these ﬁndings suggested that Kindlin-
2 plays a diverse role in cancer progression. However, little is
known about the regulation of Kindlin-2 itself. Therefore,
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lin-2 is regulated will help to understand the complex role of Kind-
lin-2 in human cancers.
GLI1, as a member of the Krüppel family of zinc ﬁnger proteins,
is an effecter of Hedgehog signaling that plays an important role in
cancer development. GLI1 regulates proliferation and differentia-
tion in various cell types as well as the morphogenesis of a variety
of tissues and organs during embryo development [16]. GLI1 was
upregulated in several types of human cancers including malignant
glioma [17], prostate cancer [18] and pancreatic cancer [19]. Albeit
GLI1 was known to be a transcriptional activator in most cases, the
N terminus of Gli1 was found to recruit components of histone
deacetylase complexes [20], suggesting that GLI1 might inhibit
transcription under certain circumstances that were rarely known.
In the current investigation, we aimed to understand the mech-
anism of how Kindlin-2 is regulated. To this end, we identiﬁed that
Kindlin-2 is a novel target of GLI1 by demonstrating that GLI1
inhibits the transcription of Kindlin-2 in both normal and cancer
cells through GLI1 occupancy onto the promoter of Kindlin-2;
whereas Kindlin-2 upregulated GLI1 expression in a HH receptor
Smoothened independent manner. These data indicated a regula-
tory loop between GLI1 and Kindlin-2 that regulates cancer cell
viability, which suggests that targeting Kindlin-2 might be a new
choice for cancer therapeutics.
2. Materials and methods
2.1. Cell culture
HKC cells were maintained in H-DMEM: F12 medium (Gibco),
DU-145 and PC-3 cells were maintained in RPMI 1640 supple-
mented with 10% FBS (Hyclone), 100 U/ml penicillin, 100 lg/ml
streptomycin (Invitrogen). PC-3 and DU-145 cells were treated
with cyclopamine (Sigma) for various time points in different
experiments.
2.2. Plasmids and antibodies
Human Kindlin-2 full length cDNA was cloned from prostate
cancer cDNA library (Clontech) into pCMV 3 Flag vector as re-
ported [21] Flag-GLI1 plasmid was prepared as described in [22].
Kindlin-2 promoter full length sequence (1565 to +1334)was pre-
pared as described in [21], and the different truncation forms of
Kindlin-2 were cloned into pGL4.21-null vector (Promega) using
the following primers: fragment 241 to +293: Forward primer:
50-CTCGAGCTTCATTTCCATAA, Reverse primer: 50-AAGCTTTAGCG
GACCGCGGAGGGCTTCAC-30; fragment 207 to +293: Forward
primer: 50-CTCGAGGCCGCGCCCCCCGCCACC-30, Reverse primer:
50-AAGCTTTAGCGGACCGCGGAGGGCTTCAC-30; fragment 195 to
+293: Forward primer: 50-CTCGAGCCGCCACCCCCGCGCCGC-30,
Reverse primer: 50-AAGCTTTAGCGGACCGCGGAGGGCTTCAC-30;
fragment 77 to +293: Forward primer: 50-CTCGAGAGGGCAGCTCT
GCGGGCGGCGAA-30, Reverse primer: 50-AAGCTTTAGCGGACCGC
GGAGGGCTTCAC-30; Kindlin-2 polyclonal antibody was prepared
as described in [9], mouse monoclonal antibodies for GLI1(D-1),
Bcl-2(N-19) and Bax(B-9) were purchased from Santa Cruz Biotech-
nology Inc. (CA, USA). Rabbit polyclonal antibody for PCNA was the
product of Lab Vision (Fremont, CA, USA), and mouse monoclonal
antibody for Actin was purchased from Beijing Zhongshan Inc.
(China).
2.3. Small interference RNAs
The sequences of the siRNA used in this research were: Kindlin-
2 siRNA: 50-AAGCUGGUGGAGAAACUCG-30; GLI1 siRNA: 50-AACUCCACAGGCAUACAGGAUTT-30 Negative control siRNA: 50-UUCUCCG
AACGUGUCACG-30 (Qiagen). The siRNA was transfected using Lipo-
fectamine 2000 (Invitrogen) at a concentration of 10 lM in serum-
free medium.
2.4. Generation of PC-3 stable cells expressing Kindlin-2 shRNA
The generation of Kindlin-2 shRNA stably expressing PC-3 cells
was described in [13].
2.5. Luciferase reporter assays
PC-3 and DU-145 cells were seeded into 24-well plates one day
before transfection, 200 ng of different Kindlin-2 promoter trunca-
tion plasmids and 4 ng of Renilla plasmid were transfected with
Lipofectamine 2000. 200, 400 or 600 ng of Flag-GLI1 plasmids were
co-transfected as indicated per well. The reporter activity was
measured at 24 h post transfection using a Dual-luciferase Repor-
ter Assay System (Promega).
2.6. Quantitative real-time PCR
RNA was prepared using Trizol Reagent (Invitrogen) and rever-
sely transcribed with TaqMan (Applied Biosystems) using random
primers as described by the manufacturer. cDNA was prepared for
quantitative real-time PCR reactions using SYBR Green Realtime
PCR Master Mix (Toyobo) and 0.5 lM of each primer. Triplicate
reactions were analyzed using the iCycler iQ (Bio-Rad Laboratories)
with melt curve analysis. Relative expression was calculated by
correcting for Ct value differences for human actin loading. Empty
vector and siRNA control were set to 1 and the relative fold
changes of indicated mRNA were graphed. The primers used were:
human Kindlin-2 Forward primer: 50-TGTCCCCGCTATCTAAAAAA
GT-30, Reverse primer: 50-TGATGGGCCTCCAAGATTCT-30; human
GLI1 Forward primer: 50-GGGATGATCCCACATCCTCAGTC-30, Re-
verse primer: 50-CTGGAGCAGCCCCCCCAGT-30.
2.7. Chromatin immunoprecipitation (ChIP)
Chip was performed using EZ-ChIP™ kit (Millipore) as described
by the manufacturer. Brieﬂy, approximately 1  107 PC-3 cells
were crosslinked in PBS containing 1% formaldehyde for 10 min
at room temperature followed by 0.125 M glycine treatment for
5 min at room temperature. Nuclei extract was isolated and DNA
was sonicated to an average length of 0.2–1 kb. Soluble chromatin
was diluted to 1 ml with dilution buffer and precleared using 60 ll
Protein G Agarose. Immunoprecipitations were performed using
10 lg mouse monoclonal anti-GLI1 antibody (Santa Cruz) or
mouse IgG control (Sigma) at 4 C overnight. Immunoprecipitates
were washed sequentially by low salt wash buffer, high salt wash
buffer, LiCl wash buffer and TE wash buffer. Crosslinks were re-
versed by incubation at 65 C with rotation for 4 h. And then the
DNA was elucidated into collection tubes. The DNA samples were
analyzed by real-time PCR using the iCycler iQ (Bio-Rad Laborato-
ries). The primers used in ChIP assay were: Kindlin-2: Primer1:
Forward: 50-AGTCCAGCCTGAGCTCTAG-3’; Reverse: 50-CTAATGG
AGTCCCGTCGTC-30. Primer2: Forward: 50-AGACTGCATTG TTTGG
CTCCCT-30; Reverse: 50-TCAGTCACCTTCAACAGCTCCT-30. PTCH1:
Forward: 50-CCTTAATGGAAGTATTGCATGCG-3’; Reverse: 5’- CTG
TCAGATGGCTTGGGTTTCTG -3’.
2.8. WST-1 cell viability assay
Kindlin-2 shRNA or control shRNA stably expressing PC-3 cells
were seeded into 96 wells plate with 4000 cells in each well, the
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24 h later the cells were treated with 10 lM cyclopamine or DMSO
for 72 h. 4-[3-(4-Idophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-
1,3-benzene disulfonate to formazan (WST-1 reagent, Beyotime,
Shanghai) was added following the manufacturer’s instruction,
and incubated at 37 C for 100 min. Dye conversion at the absor-
bance of 450 nm was ascertained by a Bio-Rad Microplate Reader.
2.9. Immunoﬂuorescent assay
Immunoﬂuorescence for cells was performed as described in
[13].
2.10. Statistical analyses
All average values were presented as means ± S.E.M. Data were
analyzed using GraphPad Prism 5 software. A probability level of
less than 0.05 was considered signiﬁcant.
3. Results
3.1. GLI1 negatively regulates Kindlin-2 expression at the
transcriptional level
We have recently demonstrated that Kindlin-2 regulates the
drug sensitivity of prostate cancer cells [13]. However, the mecha-
nism remained to be elucidated. To this end, Hedgehog signalingFig. 1. GLI1 negatively regulates the expression of Kindlin-2. (A) PC-3 cells were transfec
determine the protein level of GLI1 and Kindlin-2. (C) HKC cells were transiently tran
analyzed by immunoblot to determine the protein level of Kindlin-2 or GLI1. Data were r
of Kindlin-2 protein shown in (A) and (C) as compared with actin. (E) HKC cell was tr
quantitative RT-PCR was performed to measure the mRNA level of GLI1 and Kindlin-2
P < 0.05; and  means P < 0.01. The results represent the means ± S.E.M. of three separahas been known to play an important role in the regulation of pros-
tate cancer progression [18,23]. We then interested in scrutinizing
the possible link between Kindlin-2 and the SHH effector GLI1 in
prostate cancer cells. Surprisingly when we knocked down the
endogenous expression of GLI1 in PC-3 cells we found that Kind-
lin-2 protein level was increased (Fig. 1A and B for quantiﬁcation).
Then we transiently transfected Flag-GLI1 cDNA into HKC cells in
which the endogenous expression of GLI1 is low, we found that
the Kindlin-2 protein was signiﬁcantly decreased (Fig. 1C and D
for quantiﬁcation). These data suggested that there is a mutual reg-
ulation between GLI1 and Kindlin-2 in cells. To clarify if this regu-
lation happens at transcriptional or posttranscriptional levels, we
examined the expression of Kindlin-2 at mRNA level. As indicated
in Fig. 1E, the Kindlin-2 mRNA was signiﬁcantly decreased under
the expression of GLI1. This suggests that GLI1 regulation on Kind-
lin-2 is at the transcriptional level.
3.2. Inhibition of Hedgehog signaling by cyclopamine upregulates
Kindlin-2 in prostate cancer cells
Next we detected whether the inhibition of Hedgehog signaling
by cyclopamine, a speciﬁc inhibitor of Smoothened could mimic
the effect of GLI1 in prostate cancer cells. DU-145 and PC-3 cells
were treated with cyclopamine (10 lM) for different times from
1 h up to 24 h. Indeed, we found that Kindlin-2 protein was in-
creased 4 h after treatment, and reached to a peak at 8 h, after that
the Kindlin-2 protein was gradually decreased both in DU-145ted with control siRNA or GLI1 speciﬁc siRNA, immunoblot assay was performed to
sfected with empty vector and GLI1 expressing vector, and total cell lysates were
epresentative of three independent experiments. (B) and (D) Relative quantiﬁcation
ansiently transfected with GLI1, 48 h later the mRNA was extracted and real-time
. Each sample was assayed in triplicate in four independent experiments. means
te experiments.
Fig. 2. The expression of Kindlin-2 is negatively correlated with Hedgehog signaling activity. DU-145 (A) and PC-3 (B) were treated with 10 lM cyclopamine for the indicated
time periods, and then the total cell lysates were harvested and analyzed by immunoblot assay. Data are representative of three independent experiments. (C) Relative
quantiﬁcation variation curve of Kindlin-2 protein shown in (A) and (B) as compared with actin; Data are expressed as mean ± S.E.M. (n = 3). ⁄P < 0.05, ⁄⁄P < 0.01. (D)
Endogenous expression pattern of GLI1 and Kindlin-2 were analyzed by immunoblot in DU-145 and PC-3, the Kindlin-2 protein level was negatively correlated with GLI1 in
PC-3 and DU-145 cells.
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lin-2 is an early response gene of Hedgehog signaling. In the early
stage (0–8 h), inhibition of Hedgehog signaling signiﬁcantly in-
creased Kindlin-2 protein, while in the late stage (8–24 h), Kind-
lin-2 protein was gradually decreased despite the presence of
cyclopamine (Fig. 2C). These ﬁndings suggest that Kindlin-2 is a
new regulatory target of Hedgehog signaling and the decreased
protein level of Kindlin-2 at the later stage (8–24 h) might be
caused by degradation pathways that Kindlin-2 involved in, which
yet to be identiﬁed.
In order to see whether endogenous GLI1 in prostate cancer
cells play a role in regulating Kindlin-2 expression, we compared
the Kindlin-2 levels in two prostate cancer cell lines including
PC-3 and DU-145. Immunoblotting results showed that DU-145
cells expressing higher level of GLI1 [24] had a lower Kindlin-2
level, while PC3 cells having lower expression of GLI1 exhibited a
higher level of Kindlin-2, thus supporting the negative correlation
between GLI1 and Kindlin-2.3.3. GLI1 occupies the promoter region of Kindlin-2 and inhibits its
transcriptional activity
To unravel whether GLI1 downregulates Kindlin-2 through
inhibiting the transcriptional activity of Kindlin-2 promoter, we
cloned a nearly 3 kb genomic sequence covering the 1565 to
+1334 region of human Kindlin-2 gene as described before [21]
(Fig. 3A), which referred to as Kindlin-2 full length (FL) promoter
in the following text. Then we transfected the reporter constructs
of Kindlin-2 promoter into PC-3 and HKC cells, the promoter was
functional as compared with empty vector (Fig. 3B and C), and
its activity was inhibited by co-transfected GLI1 in a dose depen-
dent manner (Fig. 3B and C). This result conﬁrmed that the inhibi-
tion Kindlin-2 expression indeed occurs at transcriptional level. In
silico assay using Matinspector software suggested that there was
one potential GLI1 binding sites in Kindlin-2 promoter (Fig. 3A),
which located at 204 to 196, and next we constructed several
Kindlin-2 promoter deletion mutants to detect whether this site
Fig. 3. GLI1 inhibits the expression of Kindlin-2 through occupying toKindlin-2 promoter region. (A) Schematic diagram of the Kindlin-2 promoter. Black elliptic point
indicates the putative GLI1 binding site. TSS, for transcriptional start site; ATG, indicating the translational start site; E1 and E2, representing exon 1 and exon 2, respectively.
The arrows show the primer 1. (B) Kindlin-2 promoter FL was transfected into PC-3 with or without different amounts of GLI1 expression vector (with quantity ratios of 1:1,
1:2 and 1:3 between Kindlin-2 promoter FL and GLI1). (C) The same as (B) except that the assay was performed in HKC cells. (D) Different Kindlin-2 promoter deletion
mutants were co-transfected with GLI1 with a ratio of 1:1 into PC-3. Note that the inhibitory effect of GLI1 on Kindlin-2 promoter was diminished when the predicted binding
site is deleted; the luciferase activities were normalized with Renilla luciferase reporter gene. Data are representative of three independent experiments. (E) ChIP was
performed on PC-3 using GLI1 monoclonal antibody. Quantitative real-time PCR was performed to measure enrichment at the predicted binding site, Primer1, as shown in (A),
Primer 2 was 4 kb upstream of Kindlin-2 TSS. Data are expressed as mean ± S.E.M. (n = 3). ⁄P < 0.05, ⁄⁄P < 0.01.
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lin-2 promoter. Our results showed that the transcriptional activity
of 241 to +293 region was comparable with that of the FL pro-
moter (data not shown), and it was moderately inhibited to a sim-
ilar extent as the FL by GLI1. Similar effect was also observed in the
region of 207 to +293 (Fig. 3C). However, the transcriptional
activity of region 195 to +293 that does not include the potential
binding site could not be reduced by GLI1 (Fig. 3C), suggesting that
the binding site located between 207 and 195 mediated the ef-
fect of GLI1 on Kindlin-2 promoter.
To conﬁrm that GLI1 can occupy the Kindlin-2 promoter, we
performed chromatin-immunoprecipitation PCR (ChIP-PCR) using
GLI1 antibody in the assay. PTCH1 is a known target of GLI1, thus
we detected ﬁrstly whether PTCH1 promoter was enriched in GLI1
immunoprecipitates. Data shown that PTCH1 promoter was indeedenriched by GLI1, suggesting the ChIP-PCR using GLI1 antibody
was successful. Then we performed the formal experiment and
found that GLI1 indeed could associate with Kindlin-2 promoter
region that contains a GLI1 occupancy site as compared with IgG
control (Fig. 3E). However, we did not detect the enrichment of
50-Kindlin-2 4 kb upstream region. These data clearly indicated
that GLI1 regulate Kindlin-2 expression through occupying its 50
promoter region.
3.4. Kindlin-2 positively regulates GLI1
Given that cyclopamine has a two-phase effect on the regula-
tion of Kindlin-2, we hypothesized that the effect of cyclopamine
was regulated by a feedback loop. Thus we knocked down Kind-
lin-2 using siRNA in PC-3 and found that GLI1 mRNA and protein
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pression of Kindlin-2 also increased the mRNA and protein of GLI1
(Fig. 4B and D, respectively). These results demonstrated that there
was indeed a feedback loop between Kindlin-2 and GLI1.
To identify the mechanism accounting for the feedback loop, we
examined whether the feedback loop was functional in the
presence of cyclopamine. In consistence with previous studies
[18,25], GLI1 was found decreased by the inhibition of Smoothened
using cyclopamine (Fig. 4D ﬁrst lane and third lane). However, the
presence of Kindlin-2 signiﬁcantly reduced the effect of cyclop-
amine on GLI1 (Fig. 4D). It has been reported that activated glyco-
gen synthase kinase 3b (GSK3b) phosphorylates GLI1 and induces
its degradation [26]. In this regards, we inhibited GSK3b activity
and found a signiﬁcant increase in GLI1 protein level. Phosphoryla-
tion of Ser-9 was taken as an indicator of GSK3b inhibition. Inter-
estingly, the inhibition of GSK3b can be partially reversed by
Kindlin-2 knockdown, which slightly decreased the phosphoryla-
tion of GSK3b at Ser-9 and signiﬁcantly reduced GLI1 (Fig. 4E).
These results suggested that Kindlin-2 positively regulates GLI1,
a mechanism that is independent of Smoothened but partiallyFig. 4. Kindlin-2 positively regulates GLI1. (A) PC-3 was transfected with control siRNA
quantitative real-time PCR and normalized to actin. (B) PC-3 was transfected with contr
quantiﬁed by quantitative real-time PCR and normalized to actin. (C) PC-3 was transfected
protein expression was assessed by immunoblot analysis with the indicated antibodies.
cyclopamine for 24 h, then the cell extracts were prepared and protein expression w
transfected with control siRNA or Kindlin-2 siRNA, and treated with LiCl 40 mM for 24 h
upper panel, the quantiﬁcation of GLI1was shown in lower panel. Data are expressed asthrough inhibition of GSK3b without exclusion of other
mechanisms.
3.5. Kindlin-2 facilitates the sensitivity of prostate cancer cells to
cyclopamine induced cell death
It was known that cyclopamine can induce cell death in pros-
tate cancer cells [18]. In view of the above results, we wondered
whether Kindlin-2 is involved in the drug sensitivity of prostate
cancer cells to cyclopamine. Importantly, apoptosis induced by
cyclopamine was indeed increased when Kindlin-2 was knock-
down (Fig. 5A). In support of this result, Kindlin-2 knockdown
increased ratio of Bax/Bcl-2 induced by cyclopamine in PC-3 cells,
while the ratio was unchanged in Kindlin-2 knockdown cells with-
out the presence of cyclopamine. In addition, the cell proliferation
remained unchanged indicated by proliferating cell nuclear anti-
gen (PCNA) (Fig. 5B). Next we treated PC-3 cells stably transfected
by Kindlin-2 shRNA with 10 lM cyclopamine for 72 h, then
detected the cell viability using WST-1. Our data showed that
although Kindlin-2 shRNA alone has no effect on PC-3 cell viability,or Kindlin-2 siRNA for 48 h, mRNA levels of GLI1 and Kindlin-2 were quantiﬁed by
ol vector or Kindlin-2 constructs for 48 h, mRNA levels of GLI1 and Kindlin-2 were
with control siRNA or Kindlin-2 siRNA, 48 h later the cell lysates were prepared and
(D) PC-3 was transfected with control vector or Kindlin-2 and treated with 10 lM
as assessed by immunoblot analysis with the indicated antibodies. (E) PC-3 was
. Then immunobloting was carried out using the indicated antibodies as shown in
mean ± S.E.M. (n = 3). ⁄P <0.05. ⁄⁄P <0.01.
Fig. 5. Knockdown of Kindlin-2 facilitates the sensitivity of PC-3 to cyclopamine induced cell death. (A) PC-3 was transfected with Kindlin-2 siRNA 48 h before treatment with
cyclopamine for another 48 h. Then the cells were ﬁxed and the nuclei were stained with Hoechst 33342. Typical ﬁelds of phase contrast microscopy and ﬂuorescence
microscopy were captured and positive apoptotic cells were indicated with white arrows. The boxed fractions were magniﬁed and shown under the corresponding images.
Bar, 40 lm. (B) PC-3 was treated as in (A) and the cell lysate was harvested and immunoblotted with indicated antibodies. (C) PC-3 stably transfected with control shRNA or
Kindlin-2 shRNA were treated with 10 lM cyclopamine for 72 h, and then cell viability was measured using WST-1. Data are expressed as mean ± S.E.M. (n = 3). ⁄P <0.05.
⁄⁄P <0.01.
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(Fig. 5C). These data suggested that knockdown of Kindlin-2 in
combination with addition of cylcopamine could be a way of killing
prostate cancer cells.
4. Discussion
Increasing evidences have implied the important roles of Kind-
lin-2 in cancer progression, thus elucidating the molecular mecha-
nisms that regulate Kindlin-2 is greatly signiﬁcant. Herein, we
ﬁrstly identify that Kindlin-2 is a transcriptional target of GLI1,
and overexpression of GLI1 not only reduces the Kindlin-2 protein
level but also the mRNA level. Moreover, GLI1 was found to occupy
the Kindlin-2 promoter region and inhibits its transcriptional
activity. Adversely, Kindlin-2 positively regulates GLI1expression.
Collectively, our ﬁndings demonstrate a feedback regulatory loop
between Kindlin-2 and GLI1.
Although GLI1 acts as a transcriptional activator in most cases,
it has also been suspected to inhibit transcription in certain cir-
cumstance [20]. However, there is no direct evidence supporting
this hypothesis until now. Therefore, our results that GLI1 confers
an inhibitory effect on Kindlin-2 expression provided a new para-
digm for the transcriptional suppressive role of GLI1.
It has been reported that TGF-b induced the expressions of GLI1
and GLI2 [27] in a Smoothened independent pathway. Interest-
ingly, Kindlin-2 expression can also be induced by TGF-b [28]. ThusKindlin-2 is likely to act as a molecule crosstalking between TGF-b
and Hedgehog signaling pathways. Joost et al. [29] has reported
that GLI1 knockdown promoted the epithelial to mesenchymal
transition (EMT) transition in pancreatic cancer. Similarly, Kind-
lin-1 can also induce EMT process in breast cancer [30]. Consider-
ing the functional similarity between Kindlin-1 and Kindlin-2, it is
likely that Kindlin-2 participates in the EMT process induced by
GLI1 knockdown in pancreatic cancer [29], and further studies
are needed to test this hypothesis.
Intriguingly, both Kindlin-2 and GLI1 are usually found to be
upregulated in a variety of cancers, and this seems to be contro-
versy to the current ﬁnding that GLI1 inhibits Kindlin-2 expression.
However, considering the fact that TGF-b signaling upregulates
Kindlin-2 [28], maintenance of high expressions of both Kindlin-
2 and GLI1 is reasonable. Therefore, disruption of the regulation
between Kindlin-2 and GLI1 by knockdown of Kindlin-2 enhanced
the drug sensitivity of prostate cancer cells to cyclopamine. In
summary, our ﬁndings demonstrated a novel negative regulatory
role of GLI1 on target genes, a mechanism that is reﬂected in the
transcriptional repression on Kindlin-2 expression.
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